版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、Complications Related To Endoscopic Retrograde Cholangiopancreatography: A Comprehensive Clinical Review,,Abstract,over 500,000 ERCP yearly in USindications, contraindications, potential complications, benefits,
2、and alternatives to ERCP.,,contraindications,Absolute contraindications pharyngeal or esophageal obstructionactive coagulopathy anaphylactic reaction to contrast dye Relative contraindicationsportal hyperten
3、sion with esophageal and/or gastric varicesacute pancreatitis (except gallstone pancreatitis) recent myocardial infarctionsevere cardiopulmonary disease,Peri-procedural antibiotic,high-risk for developing infect
4、ive endocarditis ,artificial prosthetic implant infections Antibiotics should be continued for 48-72 hours,Complications,pancreatitis cholangitisduodenal hemorrhagestent migrationduodenal perforation ……,Complic
5、ations,Short-term complications( 3 days)mainly infections associated with indwelling stents and inflammatory changes secondary to ductal manipulation.,pancreatitis,1% to 6%(a) new-onset or worsening abdom
6、inal pain (b) elevation of serum amylase three times above normal at 24 hours post procedure(c) requirement for >2 days of pancreatitisrelated hospitalization,risk factors,previous post-ERCP pancreatitis suspected
7、 sphincter of Oddi dysfunction, female genderabsence of chronic pancreatitisballoon dilatation of the biliary sphincterdifficult cannulationpancreatic sphincterotomy>1 injections of contrast into the p
8、ancreatic ductage <60 years,,three risk factors for post-ERCP pancreatitis were present: age 1 injection of contrast. Pancreatitis resolved following five days of hospitalization.,,one study, stent placement enhan
9、ced ductal drainage past the hypertensive sphincter and reduced the incidence of pancreatitis from 26% to 7%.pharmacologic interventions:Neither somatostatin, nor its analogue, octreotide, appeared to reduce the r
10、ate of post-ERCP pancreatitis,Hemorrhagic complications,1-2%(A) Positioning of the ERCP equipment for a sphincterotomy; (B) Post-sphincterotomy oozing that evolved into (C) continued bleeding requiring epi
11、nephrine injection for control. (D) Self-limited post-sphincterotomy bleeding.,Perforations,0.3% to 0.6%(a) guidewire-related perforations (b) peri-ampullary perforations during sphincterotomy; (c) perfo
12、rations that are remote from the papilla,Perforations,Retroperitoneal duodenal perforation following ERCP and sphincterotomy. The patient underwent successful nonoperative therapy: bowel rest, nasogastric suctioning
13、, and broad-spectrum antibiotics,Cholangitis,1-3%Adequate biliary drainage stents and nasobiliary tubes,Cholecystitis,0.5% cholecystectomy,Complications of sphincterotomy,pancreatitis (5.2-5.4%) hemorrhage (2.0%)
14、,stent placement/manipulation,stent obstruction (often leading to infection/cholangitis)stent migrationrecurrent ductal stenosis post-stent removalPancreatitisbleeding,ERCP in pregnancy,Although symptomatic
15、gallstone disease is common in pregnant women (incidence >10%), choledocholithiasis requiring intervention during pregnancy is rare (incidence <1%) postpartum period or until second trimester, relatively safe
16、r.,Conclusions,Operator experience, avoidance of unnecessary procedures, adequate pre-procedural preparation, and meticulous attention to detail during the procedure, all contribute to minimizing the risk of ERCP-related
溫馨提示
- 1. 本站所有資源如無(wú)特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 眾賞文庫(kù)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
評(píng)論
0/150
提交評(píng)論